These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 17268551)

  • 21. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.
    van Zoelen MA; Yang H; Florquin S; Meijers JC; Akira S; Arnold B; Nawroth PP; Bierhaus A; Tracey KJ; van der Poll T
    Shock; 2009 Mar; 31(3):280-4. PubMed ID: 19218854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration.
    Ding ZM; Babensee JE; Simon SI; Lu H; Perrard JL; Bullard DC; Dai XY; Bromley SK; Dustin ML; Entman ML; Smith CW; Ballantyne CM
    J Immunol; 1999 Nov; 163(9):5029-38. PubMed ID: 10528208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
    Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
    Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products.
    Dumitriu IE; Baruah P; Valentinis B; Voll RE; Herrmann M; Nawroth PP; Arnold B; Bianchi ME; Manfredi AA; Rovere-Querini P
    J Immunol; 2005 Jun; 174(12):7506-15. PubMed ID: 15944249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role of RAGE and HMGB1 in inflammatory heart disease.
    Bangert A; Andrassy M; Müller AM; Bockstahler M; Fischer A; Volz CH; Leib C; Göser S; Korkmaz-Icöz S; Zittrich S; Jungmann A; Lasitschka F; Pfitzer G; Müller OJ; Katus HA; Kaya Z
    Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E155-64. PubMed ID: 26715748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway.
    Cai W; Duan XM; Liu Y; Yu J; Tang YL; Liu ZL; Jiang S; Zhang CP; Liu JY; Xu JX
    Biomed Res Int; 2017; 2017():4391920. PubMed ID: 28116308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia.
    Achouiti A; van der Meer AJ; Florquin S; Yang H; Tracey KJ; van 't Veer C; de Vos AF; van der Poll T
    Crit Care; 2013 Dec; 17(6):R296. PubMed ID: 24342460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4.
    Wang C; Wang H; Chang DY; Hao J; Zhao MH; Chen M
    Arthritis Res Ther; 2015 Mar; 17(1):64. PubMed ID: 25889374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
    Riuzzi F; Sorci G; Donato R
    J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen.
    Chavakis T; Kanse SM; Pixley RA; May AE; Isordia-Salas I; Colman RW; Preissner KT
    FASEB J; 2001 Nov; 15(13):2365-76. PubMed ID: 11689462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular protein disulfide isomerase regulates ligand-binding activity of αMβ2 integrin and neutrophil recruitment during vascular inflammation.
    Hahm E; Li J; Kim K; Huh S; Rogelj S; Cho J
    Blood; 2013 May; 121(19):3789-800, S1-15. PubMed ID: 23460613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term heat exposure inhibits inflammation by abrogating recruitment of and nuclear factor-{kappa}B activation in neutrophils exposed to chemotactic cytokines.
    Choi M; Salanova B; Rolle S; Wellner M; Schneider W; Luft FC; Kettritz R
    Am J Pathol; 2008 Feb; 172(2):367-777. PubMed ID: 18187571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway.
    Kim SW; Lim CM; Kim JB; Shin JH; Lee S; Lee M; Lee JK
    Neurotox Res; 2011 Aug; 20(2):159-69. PubMed ID: 21116767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
    Huttunen HJ; Fages C; Rauvala H
    J Biol Chem; 1999 Jul; 274(28):19919-24. PubMed ID: 10391939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.
    Mazarati A; Maroso M; Iori V; Vezzani A; Carli M
    Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketamine attenuates high mobility group box-1-induced inflammatory responses in endothelial cells.
    Liu Z; Wang Z; Han G; Huang L; Jiang J; Li S
    J Surg Res; 2016 Feb; 200(2):593-603. PubMed ID: 26453003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRN473, an inhibitor of Bruton's tyrosine kinase, inhibits neutrophil recruitment via inhibition of macrophage antigen-1 signalling.
    Herter JM; Margraf A; Volmering S; Correia BE; Bradshaw JM; Bisconte A; Hill RJ; Langrish CL; Lowell CA; Zarbock A
    Br J Pharmacol; 2018 Feb; 175(3):429-439. PubMed ID: 29130484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fundamentally different roles for LFA-1, Mac-1 and alpha4-integrin in neutrophil chemotaxis.
    Heit B; Colarusso P; Kubes P
    J Cell Sci; 2005 Nov; 118(Pt 22):5205-20. PubMed ID: 16249234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.